Your browser doesn't support javascript.
loading
Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression.
Sallin, Michelle A; Kauffman, Keith D; Riou, Catherine; Du Bruyn, Elsa; Foreman, Taylor W; Sakai, Shunsuke; Hoft, Stella G; Myers, Timothy G; Gardina, Paul J; Sher, Alan; Moore, Rashida; Wilder-Kofie, Temeri; Moore, Ian N; Sette, Alessandro; Lindestam Arlehamn, Cecilia S; Wilkinson, Robert J; Barber, Daniel L.
Afiliación
  • Sallin MA; T Lymphocyte Biology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Kauffman KD; National Institute of Aging, National Institutes of Health, Baltimore, MD, USA.
  • Riou C; T Lymphocyte Biology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Du Bruyn E; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Foreman TW; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Sakai S; T Lymphocyte Biology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Hoft SG; T Lymphocyte Biology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Myers TG; T Lymphocyte Biology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Gardina PJ; Genomic Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Sher A; Genomic Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Moore R; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Wilder-Kofie T; Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Moore IN; Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Sette A; Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Lindestam Arlehamn CS; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Wilkinson RJ; Division of Vaccine Discovery, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
  • Barber DL; Division of Vaccine Discovery, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
Nat Microbiol ; 3(11): 1198-1205, 2018 11.
Article en En | MEDLINE | ID: mdl-30202016
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis / Expresión Génica / Ligando CD30 / Resistencia a la Enfermedad / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Microbiol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis / Expresión Génica / Ligando CD30 / Resistencia a la Enfermedad / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Microbiol Año: 2018 Tipo del documento: Article